(Q47593139)

4 February 2018

title

Endogenous restoration of noradrenaline by precursor therapy in dopamine-beta-hydroxylase deficiency (English)

1 reference

4 February 2018

0 references

1 reference

I Biaggioni

1

1 reference

4 February 2018

D Robertson

series ordinal

2

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 November 1987

1 reference

4 February 2018

published in

The Lancet

1 reference

4 February 2018

volume

2

1 reference

4 February 2018

issue

8569

1 reference

4 February 2018

page(s)

1170-1172

1 reference

4 February 2018

Isolated failure of autonomic noradrenergic neurotransmission. Evidence for impaired beta-hydroxylation of dopamine

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991317-1

7 January 2021

Congenital dopamine-beta-hydroxylase deficiency. A novel orthostatic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991317-1

7 January 2021

Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991317-1

7 January 2021

Influence of yohimbine on blood pressure, autonomic reflexes, and plasma catecholamines in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991317-1

7 January 2021

Pressor effect of L-threo-3,4-dihydroxyphenylserine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991317-1

7 January 2021

Increased vascular beta2-adrenoceptor responsiveness in autonomic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991317-1

7 January 2021

Formation of noradrenaline in the rat brain from the four stereoisomers of 3,4-dihydroxyphenylserine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991317-1

7 January 2021

The Urinary Output of Catecholamines in Narcolepsy Under Resting Conditions and Following Administration of Dopamine, Dopa, and Dops

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991317-1

7 January 2021

Mass spectrometric measurements of norepinephrine synthesis in man from infusion of stable isotope-labelled L-threo-3,4-dihydroxyphenylserine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991317-1

7 January 2021

Treatment of parkinsonism with L-threo-3,4-dihydroxyphenylserine: a pharmacokinetic study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991317-1

7 January 2021

Orthostatic hypotension in familial amyloid polyneuropathy: treatment with DL-threo-3,4-dihydroxyphenylserine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991317-1

7 January 2021

Treatment of orthostatic hypotension in Shy-Drager syndrome with DL-threo-3,4-dihydroxyphenylserine: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991317-1

7 January 2021

DL-Threo-3,4-dihydroxyphenylserine does not exert a pressor effect in orthostatic hypotension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991317-1

7 January 2021

Characteristics of enzymic decarboxylation of L-threo-3,4-dihydroxyphenylserine using hog renal L-aromatic amino acid decarboxylase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991317-1

7 January 2021

Pharmacokinetic studies of oral L-threo-3,4-dihydroxyphenylserine in normal subjects and patients with familial amyloid polyneuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991317-1

7 January 2021

10.1016/S0140-6736(87)91317-1

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018